Active substance
Dutasteride
- SFDA 3
- US FDA 20
- Health Canada 12
- US price lines 1
- NHS prices 1
- Safety 5
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| AVODART 0.5MG CAPSULE | 0.5 mg | Capsule · Oral use | 30 Blister | SAR 111.90 | NCE · Prescription | GLAXO SAUDI ARABIA | Valid |
| Duserex | 0.5 mg | Capsule, soft · Oral use | 30 Blister | SAR 81.80 | Generic · Prescription | MS Pharma Saudi (MSPS) | Valid |
| Dusta | 0.5 mg | Capsule, soft · Oral use | 30 Blister | SAR 90.90 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
Indications — CHI Daman Drug Formulary
BENIGN PROSTATIC HYPERTROPHY
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| AVODART | 0.5MG | capsule · oral | WAYLIS THERAP | Prescription | 20 Nov 2001 |
| DUTASTERIDE | 0.5MG | capsule · oral | BARR | Prescription | 21 Dec 2010 |
| DUTASTERIDE | 0.5MG | capsule · oral | CHARTWELL | Prescription | 20 Nov 2015 |
| DUTASTERIDE | 0.5MG | capsule · oral | AUROBINDO PHARMA LTD | Prescription | 20 Nov 2015 |
| DUTASTERIDE | 0.5MG | capsule · oral | AMNEAL PHARMS | Prescription | 20 Nov 2015 |
| DUTASTERIDE | 0.5MG | capsule · oral | ONESOURCE | Prescription | 20 Nov 2015 |
| DUTASTERIDE | 0.5MG | capsule · oral | ACELLA | Prescription | 17 Mar 2016 |
| DUTASTERIDE | 0.5MG | capsule · oral | ASCENT PHARMS INC | Prescription | 21 Oct 2016 |
| DUTASTERIDE | 0.5MG | capsule · oral | MARKSANS PHARMA | Prescription | 7 Apr 2017 |
| DUTASTERIDE | 0.5MG | capsule · oral | ZYDUS LIFESCIENCES | Prescription | 4 Oct 2017 |
| DUTASTERIDE | 0.5MG | capsule · oral | HUMANWELL PURACAP | Prescription | 21 Nov 2017 |
| DUTASTERIDE | 0.5MG | capsule · oral | PH HEALTH | Discontinued | 20 Nov 2015 |
| DUTASTERIDE | 0.5MG | capsule · oral | RISING | Discontinued | 20 Nov 2015 |
| DUTASTERIDE | 0.5MG | capsule · oral | ACTAVIS LABS FL INC | Discontinued | 20 Nov 2015 |
| DUTASTERIDE | 0.5MG | capsule · oral | PHARMOBEDIENT | Discontinued | 20 Nov 2015 |
| DUTASTERIDE | 0.5MG | capsule · oral | HIKMA PHARMS | Discontinued | 23 Nov 2015 |
| DUTASTERIDE | 0.5MG | capsule · oral | APOTEX | Discontinued | 24 Nov 2015 |
| DUTASTERIDE | 0.5MG | capsule · oral | PHARMOBEDIENT | Discontinued | 14 Jun 2016 |
| DUTASTERIDE | 0.5MG | capsule · oral | HERITAGE PHARMS INC | Discontinued | 13 Oct 2017 |
| DUTASTERIDE | 0.5MG | capsule · oral | STRIDES PHARMA | Discontinued | 22 Jun 2018 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| AG-DUTASTERIDE | 02485672 | 0.5 MG | CAPSULE · ORAL | ANGITA PHARMA INC. |
| APO-DUTASTERIDE | 02404206 | 0.5 MG | CAPSULE · ORAL | APOTEX INC |
| AURO-DUTASTERIDE | 02469308 | 0.5 MG | CAPSULE · ORAL | AURO PHARMA INC |
| AVODART | 02247813 | 0.5 MG | CAPSULE · ORAL | GLAXOSMITHKLINE INC |
| DUTASTERIDE | 02429012 | 0.5 MG | CAPSULE · ORAL | SIVEM PHARMACEUTICALS ULC |
| DUTASTERIDE | 02443058 | 0.5 MG | CAPSULE · ORAL | SANIS HEALTH INC |
| JAMP DUTASTERIDE CAPSULES | 02546167 | 0.5 MG | CAPSULE · ORAL | JAMP PHARMA CORPORATION |
| MINT-DUTASTERIDE | 02428873 | 0.5 MG | CAPSULE · ORAL | MINT PHARMACEUTICALS INC |
| NRA-DUTASTERIDE | 02490587 | 0.5 MG | CAPSULE · ORAL | NORA PHARMA INC |
| PRO-DUTASTERIDE | 02543990 | 0.5 MG | CAPSULE · ORAL | PRO DOC LIMITEE |
| SANDOZ DUTASTERIDE | 02424444 | 0.5 MG | CAPSULE · ORAL | SANDOZ CANADA INCORPORATED |
| TEVA-DUTASTERIDE | 02408287 | 0.5 MG | CAPSULE · ORAL | TEVA CANADA LIMITED |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | DUTASTERIDE 0.5 MG CAPSULE | $0.15702 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Dutasteride 500microgram capsules | £2.45 | 30 capsule | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 28 Dec 2020 JALYN — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - EMA PRAC 17 Apr 2020 PRAC signal: Type 2 diabetes mellitus
Action for MAH: update of the product information: No - US FDA 30 Jan 2020 AVODART — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - EMA PRAC 31 Oct 2019 PRAC signal: Type 2 diabetes mellitus
Action for MAH: update of the product information: No - EMA PRAC 16 May 2019 PRAC signal: Type 2 diabetes mellitus
Action for MAH: update of the product information: No
Combinations containing Dutasteride
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.